
TJ Parker
Co-founder of PillPack and venture capitalist at Matrix Partners. He shares his expertise on drug pricing, healthcare policy, and the pharmaceutical market.
Top 3 podcasts with TJ Parker
Ranked by the Snipd community

61 snips
May 12, 2025 • 3h 48min
Crémieux, Tess Cameron, Eoghan McCabe, Pippa Lamb, Jack Dreifuss, David Tisch, TJ Parker, Surprise U.S.-China Trade Deal, Trump EO on Drug Prices, New Air Force One in 2025?, Perplexity Valuation Surge
Join influential guests like Tess Cameron, a biotech analyst at RA Capital, and TJ Parker, co-founder of PillPack, as they explore the intricacies of drug pricing and the implications of recent healthcare policies. David Tisch from BoxGroup and Jack Dreifuss share insights on venture capital trends, while Pippa Lamb discusses the impact of U.S.-China trade dynamics on the tech industry. They dive into the complexities of healthcare costs, advocate for innovative pricing strategies, and ponder the future of AI in both healthcare and customer service.

25 snips
Jun 5, 2023 • 60min
20VC: The Largest Venture Backed D2C Consumer Exit; PillPack: $0-$300M Revenues in 5 Years & The Biggest Lessons Scaling the B2B Business to $300M in 2.5 Years with TJ Parker, Co-Founder @ PillPack
TJ Parker, co-founder and former CEO of PillPack, shares insights from transforming a small pharmacy concept into a billion-dollar company sold to Amazon. He discusses the critical importance of speed in decision-making and execution for startups. TJ reflects on the unique balance of being a CEO—setting vision while empowering others—and how childhood experiences influence his approach to entrepreneurship and parenting. He also highlights major lessons learned during the challenges of fast-paced growth and the significance of company culture in startup success.

Aug 24, 2023 • 51min
TJ Parker sold PillPack for a billion dollars
TJ Parker shares his journey from founding PillPack to selling it for a billion dollars to Amazon. He discusses offering equity for payment terms, battling pharmacy giants, operational challenges, and post-acquisition insights. Intriguingly, he also mentions being hunted by the FBI!